Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients

Diagnostic Microbiology and Infectious Disease

Volumn 32, Issue 3, 1998, Pages 191-199

  Pfaller, M ^a   Zhang, J ^a   Messer, S ^a   Tumberland, M ^b   Mbidde, E ^c   Jessup, C ^a,b,c,d   Ghannoum, M ^a,b,c,d  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UGANDA CANCER INSTITUTE   (Uganda)

^d Ctr for Med Mycol Dept of D   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BACTERIUM IDENTIFICATION; CLINICAL TRIAL; COMPUTER ANALYSIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE TRANSMISSION; DRUG SENSITIVITY; ELECTROPHORESIS; FUNGAL MENINGITIS; GEL ELECTROPHORESIS; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UGANDA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA; AFRICA SOUTH OF THE SAHARA; BACTERIAL AND FUNGAL DISEASES; DEVELOPING COUNTRIES; DISEASES; DRUGS; EASTERN AFRICA; ENGLISH SPEAKING AFRICA; EPIDEMIOLOGY; HEALTH; HIV INFECTIONS; INFECTIONS; PUBLIC HEALTH; RESEARCH REPORT; TREATMENT; UGANDA; VIRAL DISEASES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIFUNGAL AGENTS; CLUSTER ANALYSIS; CRYPTOCOCCUS NEOFORMANS; DNA, FUNGAL; DRUG RESISTANCE, MICROBIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FLUCONAZOLE; FLUCYTOSINE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KARYOTYPING; MENINGITIS, CRYPTOCOCCAL; MICROBIAL SENSITIVITY TESTS; PHYLOGENY; UGANDA;

EID: 0032444721     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(98)00095-9     Document Type: Article

References (39)

1. Barchiesi F., Hollis R.J., Messer S.A., Scalise G., Rinaldi M.G., Pfaller M.A. Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates from AIDS patients. Diagn Microbiol Infect Dis. 23:1995;99-103.
2. Berg J., Clancy C.J., Nguyen M.H. The hidden danger of primary fluconazole prophylaxis in patients with acquired immunodeficiency syndrome. Clin Infect Dis. 26:1998;186-187.
3. Brandt M.E., Hutwagner L.C., Kuykendall R.J., Pinner R.W. Comparison of multilocus enzyme electrophoresis with random amplified polymorphic DNA analysis for molecular subtyping of Cryptococcus neoformans. J Clin Microbiol. 33:1995;1890-1895.
4. Brandt M.E., Pfaller M.A., Hajjeh R.A., Graviss E.A., Rees J., Spitzer E.D., Pinner R.W., Mayer L.W. Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated cryptococcosis. J Infect Dis. 174:1996;812-820.
5. Casadevall A., Freundlich L.F., Marsh L., Scharff M. Extensive allelic variation in Cryptococcus neoformans. J Clin Microbiol. 30:1992;1080-1084.
6. Casadevall A., Spitzer E.D., Webb D. Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole. Antimicrob Agents Chemother. 37:1993;1383-1386.
7. Currie B.P., Freundlich L.F., Casadevall A. Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City. J Clin Microbiol. 32:1994;1188-1192.
8. Dromer F., Varma A., Ronin O., Mathoulin S., Dupont B. Molecular typing of Cryptococcus neoformans serotype D clinical isolates. J Clin Microbiol. 32:1994;2364-2371.
9. Franzot S.P., Hamdan J.S. In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs. Antimicrob Agents Chemother. 40:1996;822-824.
10. Franzot S.P., Hamdan J.S., Currie B.P., Casadevall A. Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States Evidence for both local genetic differences and a global clonal population structure . J Clin Microbiol. 35:1997;2243-2251.
11. Fries B.C., Chen F., Currie B.P., Casadevall A. Karyotype instability in Cryptococcus neoformans infection. J Clin Microbiol. 34:1996;1531-1534.
12. Hajjeh R.A., Brandt M.E., Pinner R.W. Emergence of cryptococcal disease Epidemiologic perspectives 100 years after its discovery . Epidemiol Rev. 17:1995;303-320.
13. Haynes K.A., Sullivan D.J., Coleman D.C., Clarke J.C.K., Emilianus R., Atkinson C., Cann K.J. Involvement of multiple Cryptococcus neoformans strains in a single episode of cryptococcosis and reinfection with novel strains in recurrent infection demonstrated by random amplification of polymorphic DNA and DNA fingerprinting. J Clin Microbiol. 33:1995;99-102.
14. Heyderman R.S., Gangaidzo I.T., Hakin J.G., Mielke J., Taziwa A., Musvaire P., Robertson V.J., Mason P.R. Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe. Clin Infect Dis. 26:1998;284-289.
15. Kwon-Chung K.J., Polacheck I., Bennett J.E. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol. 15:1982;535-537.
16. Mitchell T.G., Perfect J.R. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev. 8:1995;515-548.
17. Reference Method for Broth Dilution Antifungal Susceptibility Testing for Yeasts Approved Standard M27-A . 1997;NCCLS, Wayne, PA.
18. Nguyen M.H., Yu C.Y. In vitro comparative efficacy of voriconazole and intraconazole against fluconazole-susceptible and -resistant Cryptococcus neoformans isolates. Antimicrob Agents Chemother. 42:1998;471-472.
19. Paugam A., Dupouy-Camet J., Blanche P., Gangneux J.P., Tourte-Schaefer C., Sicard D. Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis. Clin Infect Dis. 19:1994;975-976.
20. Perfect J.R., Ketabchi N., Cox G.M., Ingram C.W., Beiser C. Karyotyping of Cryptococcus neoformans as an epidemiological tool. J Clin Microbiol. 31:1993;3305-3309.
21. Pfaller M.A., Rhine-Chalberg J., Redding S.W., Smith J., Farinacci G., Fothergill A.W., Rinaldi M.G. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol. 32:1994;59-64.
22. Pfaller MA, Zhang J, Messer SA, Brandt ME, Hajjeh RA, Jessup CJ, Tumberland M, Mbidde EK, Ghannoum MA (1998) In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob Agents Chemother. Submitted for publication.
23. Powderly W.G. Cryptococcal meningitis and AIDS. Clin Infect Dis. 17:1993;837-842.
24. Powderly W.G., Saag M.S., Cloud G.A., Robinson P., Meyer R.D., Jacobson J.M., Graybill J.R., Sugar A.M., McAuliffe V.J., Follansbee S.E., Tuazon C.U., Stern J.J., Feinberg J., Hafner R., Dismukes W.E. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med. 326:1992;793-798.
25. Powderly W.G., Keath E.J., Sokol-Anderson M. Amphotericin B-resistant Cryptococcus neoformans in a patient with AIDS. Infect Dis Clin Pract. 1:1993;314-316.
26. Powderly W.G., Finkelstein D.M., Feinberg J., Frame P.T., He W., Van der Horst C.M., Koletar S.L., Eyster M.E., Carey J., Waskin H.A., Hooton T.M., Hyslop N.E., Spector S.A., Bozzette S.A. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med. 332:1995;200-205.
27. Redding S., Smith J., Farinacci G., Rinaldi M., Fothergill A., Rhine-Chalberg J., Pfaller M. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS Documentation of in vitro susceptibility testing and DNA subtype analysis . Clin Infect Dis. 18:1994;240-242.
28. Redding S.W., Pfaller M.A., Messer S.A., Smith J.A., Prows J., Bradley L.L., Fothergill A.W., Rinaldi M.G. Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection. J Clin Microbiol. 35:1997;1761-1765.
29. Sanati H., Messer S.A., Pfaller M., Witt M., Larsen R., Espinel-Ingroff A., Ghannoum M. Multicenter evaluation of broth microdilution method for susceptibility testing of Cryptococcus neoformans against fluconazole. J Clin Microbiol. 34:1996;1280-1282.
30. Sangeorzan J.A., Bradley S.F., He X., Zarins L.T., Ridenour G.L., Tiballi R.N., Kauffman C.A. Epidemiology of oral candidiasis in HIV-infected patients Colonization, infection, treatment, and emergence of fluconazole resistance . Am J Med. 97:1994;339-346.
31. Schmid J., Voss E., Soll D.R. Computer-assisted methods for assessing strain relatedness in Candida albicans by fingerprinting with the moderately repetitive sequence Ca3. J Clin Microbiol. 28:1990;1236-1243.
32. Sneath PH, Sokal RR (1973) Numerical Taxonomy. The Principles and Practice of Numerical Classification. San Francisco: WH Freeman and Co., pp. 230-234.
33. Spitzer E.D., Spitzer S.G. Use of a dispersed repetitive DNA element to distinguish clinical isolates of Cryptococcus neoformans. J Clin Microbiol. 30:1992;1094-1097.
34. Spitzer E.D., Spitzer S.G., Freundlich L.F., Casadevall A. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet. 341:1993;595-596.
35. Sullivan D., Haynes K., Moran G., Shanley D., Coleman D. Persistence, replacement, and microevolution of Cryptococcus neoformans strains in recurrent meningitis in AIDS patients. J Clin Microbiol. 34:1996;1739-1744.
36. Van der Horst C.M., Saag M.S., Cloud G.A., Hamil R.J., Graybill J.R., Sobel J.D., Johnson P.C., Tuazon C.U., Kerkering T., Moskovitz B.L., Powderly W.G., Dismukes W.E. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med. 337:1997;15-21.
37. Varma A., Kwon-Chung K.J. Restriction fragment polymorphism in mitochondrial DNA of Cryptococcus neoformans. J Gen Microbiol. 135:1989;3353-3362.
38. Varma A., Swinne D., Staib F., Bennett J.E., Kwon-Chung K.J. Diversity of DNA fingerprints in Cryptococcus neoformans. J Clin Microbiol. 33:1995;1807-1814.
39. Warren N.G., Hazen K.C. Candida, Cryptococcus, and other yeasts of medical importance. Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., Yolken R.H. Manual of Clinical Microbiology. 6th ed. 1995;723-737 American Society for Microbiology, Washington, DC.